Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database-Reference-Cited by-同舟云学术

Incidence, Prognostic Factors and Survival for Hemangioblastoma of the Central Nervous System: Analysis Based on the Surveillance, Epidemiology, and End Results Database

Published:2020-09-09 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Yin Xiangdong,Duan Hongzhou,Yi Zhiqiang,Li Chunwei,Lu Runchun,Li Liang

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference30 articles.

1. Pathological and clinical features and management of central nervous system hemangioblastomas in von Hippel-Lindau disease.;Kanno;J Kidney Cancer VHL.,2014

2. Solid haemangioblastomas of the CNS: a review of 17 consecutive cases.;Rachinger;Neurosurg Rev.,2009

3. Surgical resection of sporadic and hereditary hemangioblastoma: our 10-year experience and a literature review.;Bründl;Surg Neurol Int.,2014

4. von Hippel-Lindau disease.;Lonser;Lancet.,2003

5. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.;Vortmeyer;Acta Neuropathol.,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual manifestations: spinal and cerebellar hemangioblastomas indicative of von Hippel-Lindau syndrome;Radiology Case Reports;2024-11

2. Understanding Adult Central Nervous System Hemangioblastomas: A Systematic Review;World Neurosurgery;2024-11

3. Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis;Journal of Clinical Neuroscience;2024-10

4. Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study;The Lancet Oncology;2024-09

5. Radiosurgically Treated Recurrent Cerebellar Hemangioblastoma: A Case Report and Literature Review;Current Oncology;2024-07-09